Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging

Topics in Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 92-103

  Bhujwalla, Zaver M ^a   Artemov, Dmitri ^a   Glockner, James ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cancer; Contrast enhanced magnetic resonance imaging; Vascularization

Indexed keywords

ANGIOGENESIS; ARTHRITIS; BLINDNESS; CONTRAST ENHANCEMENT; HUMAN; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION; WOUND HEALING;

EID: 0032759220     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-199904000-00002     Document Type: Review

References (79)

1. Goldmann, E. The growth of malignant disease in man and the lower animals, with special reference to the vascular system. Proc R Soc Med 1907;1:1-13.
2. Algire GH, Chalkley HW, Legallais FY, Park HD. Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 1945;6:73-85.
3. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539-49.
4. Alper T, Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature 1956;178:978-9.
5. Jain RK. Transport of molecules across tumor vasculature. Cancer Mestastasis Rev 1987;6:559-93.
6. Jain RK. Transport of molecules in the tumor interstitium: A review. Cancer Res 1987;47:3039-51.
7. Jain RK. Determinants of tumor blood flow: A review: Cancer Res 1988;48:2641-58.
8. Rubin P, Casarett G. Microcirculation of tumors, part I: Anatomy, function, and necrosis. Clin Radiol 1966;17:220-9.
9. Wiig H, Tveit E, Hultborn R, Reed RK, Weiss L. Interstitial fluid pressure in DMBA-induced rat mammary tumours. Scand J Clin Invest 1982;42:59-4.
10. Tozer GM, Lewis S, Michalowski A, Aber V. The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma. Br J Cancer 1990;61:250-7.
11. Falk P. Differences in vascular pattern between spontaneous and the transplanted C3H mouse mammary carcinoma. Eur J Cancer 1982; 18:155-65.
12. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - Correlation in invasive brest carcinoma. N Engl J Med 1991;324:1-8.
13. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340: 1120-4.
14. Hall MC, Zagars GK, Troncoso P, et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 1994;44:869-75.
15. Siegal JA, Uu E, Brawer MK. Topography of neovascularity in human prostate carcinoma. Cancer 1995;75:2545-51.
16. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
17. Folkman J. Anti-angiogenesis: New concept for therapy of solid tumors. Ann Surg 1972;175:409-16.
18. Denekamp J. Review article: Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br J Radiol 1993;66:181-96.
19. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce drug resistance. Nature 1997;390:404-7.
20. Greenblatt M, Shubik P. Tumor angiogenesis: Transfilter diffusion studies in the hamster by the transparent chamber technique. J Natl Cancer Inst 1968;41:111-24.
21. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-88.
22. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 1986;46:467-73.
23. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
24. Tannock IF. Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 1970;30:2470-6.
25. Hirst DG, Denekamp J, Hobson B. Proliferation kinetics of endothelial and tumour cells in three mouse mammary carcinomas. Cell Tissue Kinetics 1982;15:251-61.
26. Moses MA. The role of vascularization in tumor metastasis. In: F. William Orr, MR Buchanan, L Weiss, eds. Microcirculation in cancer metastasis. Boca Raton: CRC Press, 1991:257-76.
27. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449-65.
28. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13: 9-22.
29. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86:7311-5.
30. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-ninding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
31. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
32. Bacic M, Edwards NA, Merril MJ. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues - Short communication. Growth Factors 1995;12: 11-5.
33. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333-40.
34. Claffey KP, Shih SC, Mullen A, et al. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998;9:469-81.
35. Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as playmakers of tumor angiogenesis (Review). Int J Mol Med 1998;2: 715-9.
36. Brooks SE, Gu X, Kaufmann PM, Marcus DM, Caldwell RB. Modulation of VEGF production by pH and glucose in retinal Muller cells. Curr Eye Res 1998;17:875-82.
37. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implication for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-72.
38. Feldkamp MM, Lau N, Rak J, Kerbel RS, Guha A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 1999;81:118-24.
39. Mukhopadhyay D, Tsiokas I, Sukhatme VP. Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995;55:6161-5.
40. Bouvet M, Ellis LM, Nishizaki M, et al. Adenovirus-mediated wild type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 1998;58:2288-92.
41. Agani F, Kirsch DG, Friedman SL, Kastan MB, Semenza GL. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res 1997;57:4474-7.
42. Ausprunk DH, Knighton DR, Folkman J. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois: Role of host and preexisting graft blood vessels. Am J Pathol 1975;79:597-628.
43. Gimbrone MA, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974;52:413-27.
44. Jain RK, Ward-Hartley KA. Tumor blood flow: Characterization, modification and role in hyperthermia. IEEE Trans 1984;SU-31: 504-26.
45. Chalkley HW. Method for the quantitative morphologic analysis of tissues. JNCI 1943;4:47-53.
46. Kacemi A, Vervelle C, Uzan S, Challier JC. Immunostaining of vascular, perivascular cells and stromal components in human placental villi. Cell Mol Biol 1999;45:101-13.
47. Song CW, Levitt SH. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res 1971;31:587-89.
48. Peterson H-I. Vascular and extravascular spaces in tumors: Tumor vascular permeability. In: Peterson H-I, ed. Tumor blood circulation: Angiogenesis, vascular morphology and blood flow of experimental and human tumors. Boca Raton: CRC Press, 1979:77-85.
49. Abramovitch R, Frenkiel D, Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998;39:813-24.
50. Ostergaard L, Weisskoff RM, Chesler D, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical snalysis. Magn Reson Med 1996;36:715-25.
51. Sorensen AG, Tievsky AL, Ostergaard L, Weisskoff RM, Rosen BR. Contrast agents in functional MR imaging. J Magn Reson Imaging 1997;7:47-5.
52. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987;162: 205-10.
53. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volume by rapid T1 mapping. Magn Reson Med 1993;29:709-12.
54. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bendarski MD, Li KCP. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nature Med 1998;4:623-6.
55. 2O clearance measurements of tumor blood flow in mice. Cancer Res 1990;50:363-9.
56. Evelhoch JL. Measurement of tumor blood flow by deuterium NMR and the effects of modifiers. NMR Biomed 1992;5:290-5.
57. Ogawa S, Lee T-M, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990;14:68-78.
58. Carmeliet P, Dor Y, Herbert J-M, et al. Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998;394:485-90.
59. Sinha S, Lucas-Quesada FA, DeBruhl ND, et al. Multifeature analysis of Gd-enhanced MR images of breast lesions. J Magn Reson Imaging 1997;7:1016-26.
60. Furman-Haran E, Margalit R, Grobgeld D, Degani H. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc Natl Acad Sci USA 1996;93:6247-51.
61. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med 1997;3:780-2.
62. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57: 4777-86.
63. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
64. Ohno K, Pettigrew KD, Rapoport SI. Local cerebral blood flow in the conscious rat as measured with 14C-antipyrene, 14C-iodoantipyrine and 3H-nicotine. Stroke 1979;10:62-7.
65. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-31.
66. Kovar DA, Lewis MZ, River JN, Lipton MJ, Karczmar GS. In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors. Magn Reson Med 1997; 38:259-68.
67. Ogan MD Schmiedl U, Mosley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA; an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987;22:665-71.
68. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
69. Braunschweiger P, Schiffer LM. Effect of dexamethasone on vascular function in RIF-1 tumors. Cancer Res 1986;46:3299-303.
70. Braunschweiger P. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res 1988;48:4206-10.
71. Tozer GM, Morris CC. Blood flow and blood volume in a transplanted rat fibrosarcoma: Comparison with various normal tissues. Radiother Oncol 1990;17:153-66.
72. Su M-Y, Muhler A, Lao X, Nalcioglu O. Tumor characterization with dynamic contrast-enhanced MRI using contrast agents of various molecular weights. Magn Reson Med 1998;39:259-69.
73. Su M-Y, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med 1996;36:868-77.
74. Schwickert HC, Roberts TPL, Shames DM, et al. Quantification of liver blood volume: Comparison of ultra short T1 inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34:845-52.
75. Donahue KM, Weisskoff RM, Chesler DA, et al. Improving MR quantitation of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchange. Magn Reson Med 1996;36:858-67.
76. Yuan F, Salehi AA, Boucher Y, Vasthare US, Tuma RF, Jain RK. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 1994;54:4564-8.
77. Steel GG. Growth kinetics of tumours: Cell population kinetics in relation to the growth and treatment of cancer. Oxford: Clarendon Press, 1977.
78. Bhujwalla ZM, Artemov D, Solaiyappan M, Mao D, Backer JP. Comparison of vascular volume and permeability for tumor derived from metastatic human breast cancer cells with and without the metastasis suppressor gene nm23. In: Proceedings of 7th Scientific Meeting of the ISMRM, Philadelphia, 1999.
79. Artemov D, Bhujwalla ZM. Drug delivery to tumors: Potential of MR for measurement and prediction. In Proceedings of 7th Scientific Meeting of the ISMRM, Philadelphia, 1999.